In a letter to David Kessler, M.D., Commissioner, Food and Drug Administration, January 27, 1993, Joel Brind PhD., Baruch College, Professor of Endocrinology wrote:
..This letter is to bring to your attention a serious public health hazard associated with use of RU-486 and other anti-progestational steroids as abortifacients, namely, a markedly increased risk of breast cancer. To the best of my knowledge this issue has not been raised in any government hearings….despite the fact that increased risk of breast cancer associated with abortion of first pregnancy is well established in the literature….
What is the magnitude of the breast cancer hazard inherent in abortion? A review of relevant literature… puts the relative risk of abortion of first pregnancy at between 1.5 – 2, over and above the increased risk resulting from delaying first full-term pregnancy by any means. (For multiple abortions relative risks estimates range as high as 4 or 5.)
Quoted in “ABORTION A Briefing Book For Canadian Legislators” Campaign Life Coalition NATIONAL PUBLIC AFFAIRS OFFICE July 2002Share on Facebook